On April 22, 2024, Benitec Biopharma Inc. closed the transaction. The company has received $40,000,018 from 17 investors pursuant to exemption provided under Regulation D. The company has paid placement agent fee of $2,400,001.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.64 USD | +6.01% | +9.37% | +167.49% |
22/04 | Benitec Biopharma Inc. announced that it has received $40.000019 million in funding from a group of investors | CI |
18/04 | Sector Update: Health Care Stocks Mixed in Late Afternoon Trading | MT |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
23.48 USD | +0.77% | +3.12% | 12.26B | ||
8.64 USD | +6.01% | +9.37% | 69.27M | ||
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+167.49% | 69.27M | |
+22.56% | 46.4B | |
-1.51% | 41.75B | |
+48.83% | 41.37B | |
-3.42% | 29.71B | |
+10.13% | 26.01B | |
-20.44% | 19.52B | |
+26.45% | 12.43B | |
-0.14% | 12.18B | |
-0.47% | 12.13B |
- Stock Market
- Equities
- BNTC Stock
- News Benitec Biopharma Inc.
- Benitec Biopharma Inc. announced that it has received $40.000019 million in funding from a group of investors